Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1999 Oct;81(3):387–392. doi: 10.1038/sj.bjc.6690706

Paradoxical regulation of Bcl-2 family proteins by 17β-oestradiol in human breast cancer cells MCF-7

L K Leung 1, T T Y Wang 1
PMCID: PMC2362930  PMID: 10507761

Abstract

Tumorigenesis is related to the dysregulation of cell growth or cell death pathways. Hence, elucidation of the mechanisms involved in the modulation of pro- or anti-apoptotic proteins is important in furthering understanding of breast cancer aetiology and may aid in designing prevention and treatment strategies. In the present study, we examined the role of 17β-oestradiol on the regulation of apoptosis in the breast cancer cell line MCF-7. Using multi-probe RNAase protection assays, we found changes in the mRNA levels of several Bcl-2 family proteins upon treatment of MCF-7 cells with 17β-oestradiol. Unexpectedly, we found a paradoxical effects of 17β-oestradiol on two anti-apoptotic proteins Bcl-2 and Bcl-x. Treatment with 17β-oestradiol resulted in up-regulation of Bcl-2 mRNA and protein, but down-regulated Bcl-x(L) mRNA and protein. The effect of 17β-oestradiol on Bcl-x(L) occurred at concentration-dependent fashion. The effect was specific to 17β-oestradiol since other steroid hormones exert no effect on Bcl-x(L). Tamoxifen, an anti-oestrogen, blocked the down-regulation of Bcl-x(L) by 17β-oestradiol demonstrating this effect is oestrogen receptor-dependent. We speculate that different members of the Bcl-2 family proteins may be regulated through different pathway and these pathways may be modulated by 17β-oestradiol. © 1999 Cancer Research Campaign

Keywords: apoptosis, breast cancer, Bcl-2, Bcl-x(L), 17β-oestradiol

Full Text

The Full Text of this article is available as a PDF (120.4 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ashkenazi A., Dixit V. M. Death receptors: signaling and modulation. Science. 1998 Aug 28;281(5381):1305–1308. doi: 10.1126/science.281.5381.1305. [DOI] [PubMed] [Google Scholar]
  2. Bardelli A., Longati P., Albero D., Goruppi S., Schneider C., Ponzetto C., Comoglio P. M. HGF receptor associates with the anti-apoptotic protein BAG-1 and prevents cell death. EMBO J. 1996 Nov 15;15(22):6205–6212. [PMC free article] [PubMed] [Google Scholar]
  3. Bargou R. C., Daniel P. T., Mapara M. Y., Bommert K., Wagener C., Kallinich B., Royer H. D., Dörken B. Expression of the bcl-2 gene family in normal and malignant breast tissue: low bax-alpha expression in tumor cells correlates with resistance towards apoptosis. Int J Cancer. 1995 Mar 16;60(6):854–859. doi: 10.1002/ijc.2910600622. [DOI] [PubMed] [Google Scholar]
  4. Bursch W., Ellinger A., Kienzl H., Török L., Pandey S., Sikorska M., Walker R., Hermann R. S. Active cell death induced by the anti-estrogens tamoxifen and ICI 164 384 in human mammary carcinoma cells (MCF-7) in culture: the role of autophagy. Carcinogenesis. 1996 Aug;17(8):1595–1607. doi: 10.1093/carcin/17.8.1595. [DOI] [PubMed] [Google Scholar]
  5. Chittenden T., Flemington C., Houghton A. B., Ebb R. G., Gallo G. J., Elangovan B., Chinnadurai G., Lutz R. J. A conserved domain in Bak, distinct from BH1 and BH2, mediates cell death and protein binding functions. EMBO J. 1995 Nov 15;14(22):5589–5596. doi: 10.1002/j.1460-2075.1995.tb00246.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Farrow S. N., White J. H., Martinou I., Raven T., Pun K. T., Grinham C. J., Martinou J. C., Brown R. Cloning of a bcl-2 homologue by interaction with adenovirus E1B 19K. Nature. 1995 Apr 20;374(6524):731–733. doi: 10.1038/374731a0. [DOI] [PubMed] [Google Scholar]
  7. Fishman J., Osborne M. P., Telang N. T. The role of estrogen in mammary carcinogenesis. Ann N Y Acad Sci. 1995 Sep 30;768:91–100. doi: 10.1111/j.1749-6632.1995.tb12113.x. [DOI] [PubMed] [Google Scholar]
  8. Grillot D. A., González-García M., Ekhterae D., Duan L., Inohara N., Ohta S., Seldin M. F., Nuñez G. Genomic organization, promoter region analysis, and chromosome localization of the mouse bcl-x gene. J Immunol. 1997 May 15;158(10):4750–4757. [PubMed] [Google Scholar]
  9. Herrmann J. L., Beham A. W., Sarkiss M., Chiao P. J., Rands M. T., Bruckheimer E. M., Brisbay S., McDonnell T. J. Bcl-2 suppresses apoptosis resulting from disruption of the NF-kappa B survival pathway. Exp Cell Res. 1997 Nov 25;237(1):101–109. doi: 10.1006/excr.1997.3737. [DOI] [PubMed] [Google Scholar]
  10. Hu Y., Benedict M. A., Wu D., Inohara N., Núez G. Bcl-XL interacts with Apaf-1 and inhibits Apaf-1-dependent caspase-9 activation. Proc Natl Acad Sci U S A. 1998 Apr 14;95(8):4386–4391. doi: 10.1073/pnas.95.8.4386. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Huang Y., Ray S., Reed J. C., Ibrado A. M., Tang C., Nawabi A., Bhalla K. Estrogen increases intracellular p26Bcl-2 to p21Bax ratios and inhibits taxol-induced apoptosis of human breast cancer MCF-7 cells. Breast Cancer Res Treat. 1997 Jan;42(1):73–81. doi: 10.1023/a:1005777219997. [DOI] [PubMed] [Google Scholar]
  12. Jordan V. C. Antiestrogenic action of raloxifene and tamoxifen: today and tomorrow. J Natl Cancer Inst. 1998 Jul 1;90(13):967–971. doi: 10.1093/jnci/90.13.967. [DOI] [PubMed] [Google Scholar]
  13. Kandouz M., Siromachkova M., Jacob D., Chretien Marquet B., Therwath A., Gompel A. Antagonism between estradiol and progestin on Bcl-2 expression in breast-cancer cells. Int J Cancer. 1996 Sep 27;68(1):120–125. doi: 10.1002/(SICI)1097-0215(19960927)68:1<120::AID-IJC21>3.0.CO;2-E. [DOI] [PubMed] [Google Scholar]
  14. Kluck R. M., Bossy-Wetzel E., Green D. R., Newmeyer D. D. The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis. Science. 1997 Feb 21;275(5303):1132–1136. doi: 10.1126/science.275.5303.1132. [DOI] [PubMed] [Google Scholar]
  15. Kroemer G. The proto-oncogene Bcl-2 and its role in regulating apoptosis. Nat Med. 1997 Jun;3(6):614–620. doi: 10.1038/nm0697-614. [DOI] [PubMed] [Google Scholar]
  16. Kyprianou N., English H. F., Davidson N. E., Isaacs J. T. Programmed cell death during regression of the MCF-7 human breast cancer following estrogen ablation. Cancer Res. 1991 Jan 1;51(1):162–166. [PubMed] [Google Scholar]
  17. Leung L. K., Do L., Wang T. T. Regulation of death promoter Bak expression by cell density and 17 beta-estradiol in MCF-7 cells. Cancer Lett. 1998 Feb 13;124(1):47–52. doi: 10.1016/s0304-3835(97)00430-8. [DOI] [PubMed] [Google Scholar]
  18. McDonnell T. J., Beham A., Sarkiss M., Andersen M. M., Lo P. Importance of the Bcl-2 family in cell death regulation. Experientia. 1996 Oct 31;52(10-11):1008–1017. doi: 10.1007/BF01920110. [DOI] [PubMed] [Google Scholar]
  19. Nenci I., Marchetti E., Querzoli P. Commentary on human mammary preneoplasia. The estrogen receptor-promotion hypothesis. J Steroid Biochem. 1988;30(1-6):105–106. doi: 10.1016/0022-4731(88)90082-9. [DOI] [PubMed] [Google Scholar]
  20. Olopade O. I., Adeyanju M. O., Safa A. R., Hagos F., Mick R., Thompson C. B., Recant W. M. Overexpression of BCL-x protein in primary breast cancer is associated with high tumor grade and nodal metastases. Cancer J Sci Am. 1997 Jul-Aug;3(4):230–237. [PubMed] [Google Scholar]
  21. Pecci A., Scholz A., Pelster D., Beato M. Progestins prevent apoptosis in a rat endometrial cell line and increase the ratio of bcl-XL to bcl-XS. J Biol Chem. 1997 May 2;272(18):11791–11798. doi: 10.1074/jbc.272.18.11791. [DOI] [PubMed] [Google Scholar]
  22. Reed J. C. Bcl-2 and the regulation of programmed cell death. J Cell Biol. 1994 Jan;124(1-2):1–6. doi: 10.1083/jcb.124.1.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Saeed B., Zhang H., Ng S. C. Apoptotic program is initiated but not completed in LNCaP cells in response to growth in charcoal-stripped media. Prostate. 1997 May 15;31(3):145–152. doi: 10.1002/(sici)1097-0045(19970515)31:3<145::aid-pros1>3.0.co;2-k. [DOI] [PubMed] [Google Scholar]
  24. Sattler M., Liang H., Nettesheim D., Meadows R. P., Harlan J. E., Eberstadt M., Yoon H. S., Shuker S. B., Chang B. S., Minn A. J. Structure of Bcl-xL-Bak peptide complex: recognition between regulators of apoptosis. Science. 1997 Feb 14;275(5302):983–986. doi: 10.1126/science.275.5302.983. [DOI] [PubMed] [Google Scholar]
  25. Srinivasan A., Li F., Wong A., Kodandapani L., Smidt R., Jr, Krebs J. F., Fritz L. C., Wu J. C., Tomaselli K. J. Bcl-xL functions downstream of caspase-8 to inhibit Fas- and tumor necrosis factor receptor 1-induced apoptosis of MCF7 breast carcinoma cells. J Biol Chem. 1998 Feb 20;273(8):4523–4529. doi: 10.1074/jbc.273.8.4523. [DOI] [PubMed] [Google Scholar]
  26. Teixeira C., Reed J. C., Pratt M. A. Estrogen promotes chemotherapeutic drug resistance by a mechanism involving Bcl-2 proto-oncogene expression in human breast cancer cells. Cancer Res. 1995 Sep 1;55(17):3902–3907. [PubMed] [Google Scholar]
  27. Tsujimoto Y., Cossman J., Jaffe E., Croce C. M. Involvement of the bcl-2 gene in human follicular lymphoma. Science. 1985 Jun 21;228(4706):1440–1443. doi: 10.1126/science.3874430. [DOI] [PubMed] [Google Scholar]
  28. Wallach D., Boldin M., Varfolomeev E., Beyaert R., Vandenabeele P., Fiers W. Cell death induction by receptors of the TNF family: towards a molecular understanding. FEBS Lett. 1997 Jun 23;410(1):96–106. doi: 10.1016/s0014-5793(97)00553-x. [DOI] [PubMed] [Google Scholar]
  29. Wang T. T., Phang J. M. Effects of estrogen on apoptotic pathways in human breast cancer cell line MCF-7. Cancer Res. 1995 Jun 15;55(12):2487–2489. [PubMed] [Google Scholar]
  30. Wyllie A. H. Apoptosis and carcinogenesis. Eur J Cell Biol. 1997 Jul;73(3):189–197. [PubMed] [Google Scholar]
  31. Yang J., Liu X., Bhalla K., Kim C. N., Ibrado A. M., Cai J., Peng T. I., Jones D. P., Wang X. Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked. Science. 1997 Feb 21;275(5303):1129–1132. doi: 10.1126/science.275.5303.1129. [DOI] [PubMed] [Google Scholar]
  32. Zha J., Harada H., Yang E., Jockel J., Korsmeyer S. J. Serine phosphorylation of death agonist BAD in response to survival factor results in binding to 14-3-3 not BCL-X(L) Cell. 1996 Nov 15;87(4):619–628. doi: 10.1016/s0092-8674(00)81382-3. [DOI] [PubMed] [Google Scholar]
  33. Zhang G. J., Kimijima I., Abe R., Watanabe T., Kanno M., Hara K., Tsuchiya A. Apoptotic index correlates to bcl-2 and p53 protein expression, histological grade and prognosis in invasive breast cancers. Anticancer Res. 1998 May-Jun;18(3B):1989–1998. [PubMed] [Google Scholar]
  34. de Cupis A., Favoni R. E. Oestrogen/growth factor cross-talk in breast carcinoma: a specific target for novel antioestrogens. Trends Pharmacol Sci. 1997 Jul;18(7):245–251. doi: 10.1016/s0165-6147(97)01083-3. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES